Reckitt Benckiser Group 将来の成長

Future 基準チェック /26

Reckitt Benckiser Group利益と収益がそれぞれ年間11.3%と3.2%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に28% 12%なると予測されています。

主要情報

11.3%

収益成長率

12.0%

EPS成長率

Household Products 収益成長	8.2%
収益成長率	3.2%
将来の株主資本利益率	28.0%
アナリストカバレッジ	Good
最終更新日	15 Nov 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

OTCPK:RBGL.Y - アナリストの将来予測と過去の財務データ ( )GBP Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	15,247	2,340	2,294	2,803	13
12/31/2025	14,693	2,086	2,102	2,685	16
12/31/2024	14,227	2,190	2,118	2,680	16
6/30/2024	14,328	1,544	2,313	2,683	N/A
3/31/2024	14,468	1,589	2,251	2,660	N/A
12/31/2023	14,607	1,634	2,188	2,636	N/A
6/30/2023	15,011	2,223	2,042	2,495	N/A
3/31/2023	14,732	2,280	2,122	2,446	N/A
12/31/2022	14,453	2,337	2,201	2,397	N/A
6/30/2022	13,524	3,037	2,997	1,822	N/A
3/31/2022	13,379	1,487	2,933	1,760	N/A
12/31/2021	13,234	-63	2,869	1,697	N/A
9/30/2021	13,457	-853	2,395	1,947	N/A
6/30/2021	13,680	-1,644	1,921	2,196	N/A
3/31/2021	13,837	-253	2,477	2,857	N/A
12/31/2020	13,993	1,137	3,032	3,518	N/A
6/30/2020	13,517	-2,737	1,946	2,354	N/A
3/31/2020	13,182	-2,761	1,457	1,883	N/A
12/31/2019	12,846	-2,785	968	1,411	N/A
6/30/2019	12,699	2,276	2,058	2,495	N/A
3/31/2019	12,648	2,220	2,073	2,510	N/A
12/31/2018	12,597	2,164	2,087	2,524	N/A
6/30/2018	12,603	3,466	1,787	2,223	N/A
3/31/2018	12,026	3,421	N/A	2,357	N/A
12/31/2017	11,449	3,376	N/A	2,491	N/A
9/30/2017	10,764	2,699	N/A	N/A	N/A
6/30/2017	10,078	2,022	N/A	2,611	N/A
3/31/2017	9,779	1,876	N/A	2,517	N/A
12/31/2016	9,480	1,729	N/A	2,422	N/A
9/30/2016	9,192	1,624	N/A	2,307	N/A
6/30/2016	8,904	1,518	N/A	2,191	N/A
3/31/2016	8,889	1,631	N/A	1,988	N/A
12/31/2015	8,874	1,743	N/A	1,784	N/A
9/30/2015	8,872	1,729	N/A	1,933	N/A
6/30/2015	8,869	1,715	N/A	2,082	N/A
3/31/2015	8,853	1,689	N/A	2,091	N/A
12/31/2014	8,836	1,663	N/A	2,099	N/A
6/30/2014	8,595	1,399	N/A	1,952	N/A
3/31/2014	8,931	1,401	N/A	2,037	N/A
12/31/2013	9,266	1,402	N/A	2,121	N/A

アナリストによる今後の成長予測

収入対貯蓄率: RBGL.Yの予測収益成長率 (年間11.3% ) は貯蓄率 ( 2.6% ) を上回っています。

収益対市場: RBGL.Yの収益 ( 11.3% ) US市場 ( 15.3% ) よりも低い成長が予測されています。

高成長収益: RBGL.Yの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: RBGL.Yの収益 ( 3.2% ) US市場 ( 8.9% ) よりも低い成長が予測されています。

高い収益成長: RBGL.Yの収益 ( 3.2% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: RBGL.Yの自己資本利益率は、3年後には高くなると予測されています ( 28 %)

Reckitt Benckiser Group 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Reckitt Benckiser Group plc Updates Revenue Guidance for the Full Year 2024

Reckitt Benckiser Group plc Provides Earnings Guidance for the Year 2023

Reckitt Benckiser Group plc Provides Revenue Guidance for the Full Year 2023

Reckitt Benckiser Group plc Revises Earnings Guidance for the Full Year of 2022

Reckitt Benckiser Group plc Reaffirm Earnings Guidance for the Full Year of 2021

Recent updates

Reckitt Benckiser Reportedly Starts Talks on $7.9 Billion Homecare Assets Sale

Causeway Capital Management Discloses its Views on Reckitt Benckiser’s Nutrition Business

Reckitt Benckiser Group plc Updates Revenue Guidance for the Full Year 2024

Reckitt Benckiser Group plc Announces Board Committee Changes

Eminence Capital Builds Stake in Reckitt Benckiser

Reckitt Benckiser Group plc Announces Demise of Olivier Bohuon, an Independent Non-Executive Director

Reckitt Benckiser Group plc Declares Final Dividend for the Year Ended 31 December 2023

Reckitt Benckiser Group plc to Report First Half, 2024 Results on Jul 24, 2024

Reckitt Benckiser Group plc Announces Jeffrey Carrwill to Retire from the Board on 31 March 2024

Reckitt Benckiser Group plc Recommends Final Dividend for the Year 2023, Payable on 24 May 2024

Reckitt Benckiser Group plc Announces Board Changes

Reckitt Benckiser Group plc, Annual General Meeting, May 02, 2024

Reckitt Benckiser Group plc Appoints Marybeth Hays to the Board as Non-Executive Director

Reckitt Benckiser Group plc Announces Board Changes

Reckitt Benckiser Group plc Announces Board Changes

Reckitt Benckiser Group plc Provides Earnings Guidance for the Year 2023

Reckitt Benckiser Group plc Announces Chief Executive Officer Changes

Wexler Boley & Elgersma LLP, Miller Law LLC, Hilliard Shadowen LLP, Motley Rice LLC, and Spector Roseman & Kodroff P.C. Announce a $30 Million Class Action Settlement for Those Who May Have Purchased or Provided Reimbursement for the Drug Suboxone or Generic Suboxone

Reckitt Benckiser Group plc Announces Executive Changes

Reckitt Benckiser Group plc Provides Revenue Guidance for the Full Year 2023

Lysol Launches Air Sanitizer, the First Air-Care Product That Kills 99.9% of Airborne Viruses and Bacteria

Reckitt Benckiser Group plc to Report First Half, 2023 Results on Jul 23, 2023

Reckitt Benckiser Group plc Appoints Tamara Ingram OBE to the Board as A Non-Executive Director and Member of the Audit Committee, Effective 1 February 2023

Reckitt Benckiser Group plc Announces Directorate Change

Reckitt Benckiser Group plc to Report Fiscal Year 2022 Results on Mar 01, 2023

Reckitt Benckiser Group plc Revises Earnings Guidance for the Full Year of 2022

Reckitt Benckiser Group plc Announces Chief Executive Officer Changes

Reckitt Benckiser Group plc Announces Directorate Change

Reckitt Benckiser Group plc Recommends Interim 2022 Dividend, Payable on 14 September 2022

Reckitt Benckiser Reportedly Weighs Shelving $7 Billion Infant Nutrition Sale

Reckitt Benckiser Group plc, Annual General Meeting, May 20, 2022

Reckitt Benckiser Reportedly Looks to Complete Sale of Infant Nutrition Ops

Reckitt Benckiser Group plc Announces Sara Mathew Not Intend to Seek Re-Election as Non-Executive Director

Karo Pharma AB (publ) (OM:KARO) completed the acquisition of E45 brand and related sub-brands from Reckitt Benckiser Group plc (LSE:RKT).

Reckitt Benckiser Group plc Recommends Final 2021 Dividend, Payable on 9 June 2022

Reckitt Benckiser Group plc to Report First Half, 2022 Results on Jul 27, 2022

Reckitt Benckiser Group plc to Report Fiscal Year 2021 Results on Feb 17, 2022

Reckitt Benckiser Reportedly Mulls Sale of Baby-Food Business

Reckitt Introduces Science-Led Lysol® Pro Solutions

Yellow Wood Partners, LLC completed the acquisition of Scholl business of Reckitt Benckiser Group PLC (LSE:RB.).

Carlyle Reportedly Among Suitors for Reckitt's Chinese Infant Nutrition Arm

Reckitt Benckiser Group plc Reaffirm Earnings Guidance for the Full Year of 2021

Yellow Wood Partners, LLC (LSE:RB.) entered into an agreement to acquire Scholl business of Reckitt Benckiser Group PLC (LSE:RB.).

Reckitt Benckiser Group plc, Annual General Meeting, May 28, 2021

The Miami Marlins and RB Announce Partnership to Strengthen Ballpark Disinfection Protocols

Reckitt Benckiser Group plc (LSE:RB.) acquired Queen V.

Reckitt Benckiser Group plc Appoints Olivier Bohuon to the Board as a Non-Executive Director and Remuneration Committee, Effective January 1, 2021

Reckitt Benckiser Group plc to Report Fiscal Year 2020 Results on Feb 24, 2021

RB Introduces Bodi-Ome as First Clinically-Proven Probiotics Line That Goes Beyond Gut Health

Reckitt Benckiser Reportedly Kicks Off Sale of Some Personal Care Brands

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘